|
|
ASH 2011: Dr. Kumar - Phase II Trial of Intravenously Administered AMD3100 (Plerixafor) for Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Following a Lenalidomide-Based Initial Therapy
Shaji Kumar, MD
Mayo Clinic
Rochester, Minnesota, USA
|
|
|
12.06.11 |
To view the video full screen, click on the small
 button next to the volume control in the
lower right hand corner.
|
 related articles
|
|
print